Lusedra
More Drug Shortages in Fungal Meningitis Aftermath »
"Nov. 2, 2012 -- Safety steps taken in the wake of the fungal meningitis outbreak have worsened drug shortages, raising questions about whether the U.S. must choose between the safety and the availability of crucial medicines.
Ameridos"...
Read the More Drug Shortages in Fungal Meningitis Aftermath article »
Lusedra
LUSEDRA
(fospropofol disodium) Injection, for Intravenous Use
DRUG DESCRIPTION
LUSEDRA (fospropofol disodium injection) is an injection solution intended for intravenous administration as a sedative-hypnotic agent. LUSEDRA (fospropofol disodium injection) is an aqueous, sterile, nonpyrogenic, clear, colorless, iso-osmotic solution containing 35 mg/mL of fospropofol disodium. Fospropofol disodium is a water-soluble prodrug of propofol, chemically described as 2,6-diisopropylphenoxymethyl phosphate, disodium salt. The structural and molecular formulas are shown in Figure 1.
 |
Molecular Formula: C13H19O5PNa2
Molecular Weight: 332.24
Figure 1. Structural and Molecular Formulas of Fospropofol Disodium
The inactive components include monothioglycerol (0.25 wt%) and tromethamine (0.12 wt%). LUSEDRA (fospropofol disodium injection) has a pH of 8.2 to 9.0. LUSEDRA (fospropofol disodium injection) does not contain any antimicrobial preservatives and is intended for single-use administration.
Last reviewed on RxList: 2/10/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Lusedra Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.
Updated & New
